Novo Nordisk (NVO) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 December 2022 | 01 October 2024 | 87.72% | 40.93% |
| 01 August 2019 | 01 September 2022 | 120.69% | 29.22% |
| 01 April 2019 | 03 June 2019 | -7.41% | -35.98% |
| 03 July 2017 | 01 May 2018 | 14.48% | 17.76% |
| 01 June 2016 | 01 July 2016 | -3.39% | -34.3% |
| Total Return | 212.08% | ||
The monthly data for Novo Nordisk (exchange: XNYS symbol: NVO) was last updated 28 Feb 2026 10:22. Data for this stock is available from 01 Dec 2015 - 27 Feb 2026.
